0

Global Gynecological Cancers Therapeutics Market 2019-2023

  • Published: Feb 2019
  • Pages: 127
  • SKU: IRTNTR30925
Technavio

The 2022-2026 version of this report is just being published. Buy it now and get up to $1000 worth of free customization!

Get me the latest version! (includes COVID-19 impact)
Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The global gynecological cancers therapeutics market size will grow by USD 8.96 billion during 2019-2023. This report offers an analysis of the market based on type (uterine cancer, ovarian cancer, cervical cancer, and others) and product (targeted therapy and vaccination). The gynecological cancers therapeutics market research report further presents in-depth insights on the growth prospects of the market across Asia, Europe, North America, and ROW. The report analyzes the market’s competitive landscape and offers information on several companies including AstraZeneca, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, and Merck & Co., Inc.

Below are some of the key findings from this gynecological cancers therapeutics market analysis report

Gynecological Cancers Therapeutics Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global Gynecological Cancers Therapeutics Industry Overview

The presence of a strong pipeline and new drug approvals are critical reasons that will drive gynecological cancers therapeutics market growth. The pipeline for gynecological cancers treatment includes novel therapeutics such as targeted therapy products, gene therapy, and vaccines. These products are expected to change the course of gynecological cancer treatment as they are associated with advanced therapeutic mechanisms of action. Some of these mechanisms include cell cycle inhibition, angiogenesis inhibition, programmed death-ligand 1 (PD-L1) inhibition, and PARP inhibition. The approval of novel gynecological cancer therapeutics by the US FDA is increasing due to the efficiency of these drugs.

Moreover, the availability of advanced diagnostic modalities ensures an appropriate diagnosis of the disease by identifying targets for therapies. With the possibility of the early detection of gynecological cancer, the demand for diagnostic tools such as DNA microarray, complementary DNA fingerprinting, molecular profiling, and polymerase chain reaction to diagnose cancer in its early stage is increasing. This will drive the gynecological cancers therapeutics market to grow at a CAGR of over 14% during the forecast period.

Top gynecological cancers therapeutics companies covered in this market research report

The global gynecological cancers therapeutics market is fairly concentrated. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by companies, this gynecological cancers therapeutics industry analysis report will help clients identify new growth opportunities and design innovative strategies to improve their share in the market.

The report offers a complete analysis of various companies including:

  • AstraZeneca
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

Gynecological cancers therapeutics market segmentation based on geographic regions

  • Asia
  • Europe
  • North America
  • ROW

North America will account for the largest gynecological cancers therapeutics market share throughout the forecast period. The availability of favorable reimbursement policies and government initiatives are the major reasons for the high growth of the gynecological cancers therapeutics market in this region.

Gynecological cancers therapeutics market segmentation based on the type

  • Uterine cancer
  • Ovarian cancer
  • Cervical cancer
  • Others

The uterine cancer segment will account for the highest gynecological cancers therapeutics market share because of the high incidence of uterine cancer, increasing research activities, and initiatives by multiple organizations and governments to create awareness among patients about cancer.  

Key highlights of the global gynecological cancers therapeutics market for the forecast years 2019-2023:

  • CAGR of the market during the forecast period 2019-2023
  • Detailed information on factors that will accelerate the growth of the gynecological cancers therapeutics market during the next five years
  • Precise estimation of the global gynecological cancers therapeutics market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the gynecological cancers therapeutics industry across various geographies such as Asia, Europe, North America, and ROW
  • A thorough analysis of the market’s competitive landscape and detailed information on several vendors
  • Comprehensive details on factors that will challenge the growth of gynecological cancers therapeutics companies

 ​​We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

 

Read More Read Less

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: PIPELINE ANALYSIS

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY TYPE

  • Market segmentation by type
  • Comparison by type
  • Uterine cancer - Market size and forecast 2018-2023
  • Ovarian cancer - Market size and forecast 2018-2023
  • Cervical cancer - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by type

PART 08: CUSTOMER LANDSCAPE

PART 09: MARKET SEGMENTATION BY PRODUCT

  • Targeted therapy
  • Vaccination

PART 10: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline plc
  • Merck & Co., Inc.

PART 16: APPENDIX

  • Research methodology
  • List of abbreviations

PART 17: EXPLORE TECHNAVIO


Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

TechnavioINFORMATION SOURCES

Primary sources

  • Manufacturers and suppliers
  • Channel partners
  • Industry experts
  • Strategic decision makers

Secondary sources

  • Industry journals and periodicals
  • Government data
  • Financial reports of key industry players
  • Historical data
  • Press releases
Technavio

TechnavioDATA ANALYSIS

Data Synthesis

  • Collation of data
  • Estimation of key figures
  • Analysis of derived insights

Data Validation

  • Triangulation with data models
  • Reference against proprietary databases
  • Corroboration with industry experts
Technavio

TechnavioREPORT WRITING

Qualitative

  • Market drivers
  • Market challenges
  • Market trends
  • Five forces analysis

Quantitative

  • Market size and forecast
  • Market segmentation
  • Geographical insights
  • Competitive landscape
Interested in this report?
Get your FREE sample now!
Safe and Secure SSL Encrypted
Technavio

Single User:

2500 USD

Technavio Get the report (PDF) sent to your email within minutes.

Subscribe & Save

Get lifetime access to our
Technavio Insights

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

We offer $1000 worth of FREE customization at the time of purchase
Technavio
Enquire Before Buying
  1. Home
  2. Health Care
  3. Published Reports 2019
17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>